RisKlick AG
Risklick AG is a Swiss AI-driven company revolutionizing clinical trial protocol development for biopharmaceutical and medical device industries.
About
Risklick AG, a spin-off from the University of Bern, empowers biopharmaceutical and medical device companies to enhance trial success rates and accelerate the delivery of new treatments and medical devices to patients. Its multidisciplinary team, comprising data scientists, medical and clinical experts, and software developers, is united by a vision to revolutionize clinical trial protocols using AI technology. The company's flagship product, Protocol AI, employs cutting-edge Natural Language Processing (NLP) and Machine Learning (ML) tools to drastically reduce clinical protocol development time and cost, optimize study design, and improve compliance and safety. Risklick’s solutions enable faster, more efficient, and higher-quality clinical trial protocols, benefiting millions of patients worldwide through more rapid access to innovative therapies and medical devices.
Products & Services
- Protocol AI (AI-powered clinical trial protocol and study plan development platform)
- Study Engager (tool for automating patient engagement and feedback collection in trials)
- Deduklick (AI-powered automated deduplication solution for research and clinical data)
Use Cases & Case Studies
- Automated creation of clinical trial protocols for pharmaceutical and medical device companies
- Reduction of protocol development and amendment times
- Accelerating patient access to therapies and medical devices
- Enabling evidence-based, regulatory-compliant study designs with AI
Partnerships & Collaborations
- Debiopharm (leading Swiss biotechnology company)
- Integrated Scientific Services (ISS AG, Swiss clinical research company)
- Amazon
- OpenAI
- be-advanced
- Sitem-Insel
- University of Geneva (UNIGE)
- University of Bern (UNIBE)
Awards & Recognition
-
Contact Information
Certifications & Compliance
- ISO 27001:2022 compliance
- GDPR compliance